Correlation Between QORVO and Abcellera Biologics

Can any of the company-specific risk be diversified away by investing in both QORVO and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining QORVO and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between QORVO INC 3375 and Abcellera Biologics, you can compare the effects of market volatilities on QORVO and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in QORVO with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of QORVO and Abcellera Biologics.

Diversification Opportunities for QORVO and Abcellera Biologics

-0.54

Correlation Coefficient

QORVO  Abcellera Biologics

Excellent diversification

The 3 months correlation between QORVO and Abcellera is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding QORVO INC 3375 and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and QORVO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on QORVO INC 3375 are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of QORVO i.e., QORVO and Abcellera Biologics go up and down completely randomly.

Pair Corralation between QORVO and Abcellera Biologics

Assuming the 90 days trading horizon QORVO INC 3375 is expected to generate 0.28 times more return on investment than Abcellera Biologics. However, QORVO INC 3375 is 3.63 times less risky than Abcellera Biologics. It trades about -0.02 of its potential returns per unit of risk. Abcellera Biologics is currently generating about -0.03 per unit of risk. If you would invest  8,322  in QORVO INC 3375 on September 28, 2024 and sell it today you would lose (422.00) from holding QORVO INC 3375 or give up 5.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	86.94%
Values	Daily Returns

QORVO INC 3375  vs.  Abcellera Biologics

QORVO INC 3375

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days QORVO INC 3375 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for QORVO INC 3375 investors.

Abcellera Biologics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with QORVO and Abcellera Biologics

The main advantage of trading using opposite QORVO and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if QORVO position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.

The idea behind QORVO INC 3375 and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.